{
    "key": "2013-0208",
    "name": "Recombivax Hep B ages 11-15.  Dose 2 recommended in 4-6 months. ",
    "cdcTestId": "2013-0208",
    "changedInVersion": "1.0",
    "dateAdded": "2013-01-01T00:00:00",
    "dateUpdated": "2020-06-18T15:24:07.367",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "43",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-ADULT"
            }
        ],
        "seriesStatus": "Not complete"
    },
    "evaluationTestType": "All Valid: Forecast Test",
    "forecast": {
        "earliestDate": "2020-12-13T00:00:00",
        "forecastNum": "2",
        "pastDueDate": "2021-04-09T00:00:00",
        "recommendedDate": "2020-12-13T00:00:00"
    },
    "forecastTestType": "Recommended based on minimum interval from previous dose (catch-up)",
    "generalDescription": "This test case describes when dose #1 of the Hep B Recombivax vaccine is administered at age 12 years, that dose #2 should be administered at 4 months - 6 months later.",
    "patient": {
        "dob": "2008-01-24T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "43",
                "dateAdministered": "2020-08-13T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "MSD",
                "vaccineName": "RECOMBIVAX-ADULT"
            }
        ]
    },
    "reasonForChange": "",
    "testcaseName": "Recombivax Hep B ages 11-15.  Dose 2 recommended in 4-6 months. ",
    "vaccineGroup": "HepB"
}